CRCT - Centre de recherches en cancérologie de Toulouse

Type: Research unit evaluation report

Evaluation campaign: 2014-2015 (group A) - Published on: 18/08/2015

Institution(s) concerned: Université Toulouse 3 - Paul Sabatier - UPS , Centre national de la recherche scientifique - CNRS , Institut national de la santé et de la recherche médicale - INSERM

Disciplinary research field: Life and Earth Sciences (SVE) ; SVE2 Cellular Biology, Imaging, Molecular Biology, Biochemistry, Genomics, Systemic Biology, Development, Structural Biology

Scientific field(s): 5 - Biologie, medecine et santé

ERC panel(s): LS1 Molecular and Structural Biology and Biochemistry: molecular biology, biochemistry, biophysics, structural biology, biochemistry of signal transduction ;

Name of unit teams: CDK inhibitors in oncogenesis & tumor suppression ; Regulation of DNA replication & genetic instability in cancers ; Rho GTPases in tumor progression ; Shingolipid metabolism, cell death & tumor progression ; Angiogenesis & control of gene expression ; Protein synthesis & secretion in carcinogenesis ; RNA biology in hematological cancers ; Cell signaling & cell cycle in myeloid malignancies ; Innovating strategies for lymphoma therapies ; Epigenetics & translational research in pancreatic diseases ; Glioblastoma radioresistance: from signalling pathways to clinical trials ; Cholesterol metabolism & therapeutic innovation ; Pharmacogenomics of multiple myeloma ; Multiresolution dosimetry for radiotherapy optimization ; Alteration of transcription factors in acute leukemias ; PI3K isoforms, signalling & cancerogenesis ; RESIST@ML: drug resistance, stem cells & metabolism in acute myeloid leukemia

Keywords: Oncologie ; Pharmacologie ; Hématologie ; Biologie moléculaire ; Biologie cellulaire ; SVE2_1 ; SVE2_2